FDA Approves Oral Treatment for Spinal Muscular Atrophy August 7, 2020https://www.fda.gov/news-events/press-announcements/fda-approves-oral-treatment-spinal-muscular-atrophy FDA Approves Oral Treatment for Spinal Muscular Atrophy Evrysdi (risdiplam)